Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.81 USD | -1.21% | +3.65% | -2.73% |
05-02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.73% | 1.35B | |
+34.07% | 50.85B | |
+0.80% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.95% | 26.11B | |
-21.61% | 19.13B | |
+9.35% | 13.05B | |
+27.66% | 12.16B | |
+23.93% | 12.08B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Morgan Stanley Adjusts Price Target on Vir Biotechnology to $27 From $25, Maintains Equal-Weight Rating